Left ventricular hypertrophy

Parameters

Yes (n = 21)

No (n = 14)

p-value

OR

CI (95%)

Gender

Male

19 (64.6%)

7 (50%)

0.019

3.51

1.20 - 10.27

Female

2 (9.5%)

7 (50%)

0.33

0.43

0.08 - 2.42

Age range

<55 years

15 (71.4%)

6 (42.9%)

0.02

3.47

1.13 - 10.68

≥55 years

6 (28.6%)

8 (57.1%)

0.97

1.02

0.27 - 3.80

Medical history

HBP

17 (80.9%)

13 (92.8%)

0.18

1.87

0.75 - 4.65

Diabetes

2 (9.5%)

5 (35.7%)

1.22

0.22

0.03 - 1.59

Initial nephropathy

CGN

8 (38.1%)

9 (64.3%)

0.96

1.03

0.33 - 3.20

Hypertensive nephropathy

13 (61.9%)

3 (21.4%)

0.01

1.18

0.45 - 3.12

CTIN

0

2 (14.3%)

-

-

-

CKD stage

GFR < 15 ml/min

18 (85.7%)

12 (85.7%)

0.15

1.92

0.78 - 4.71

GFR ≥ 15 ml/min

3 (14.3%)

2 (14.3%)

0.31

3.00

0.35 - 25.87

Clinical signs

RHS

4 (19.05%)

7 (50%)

0.01

3.45

1.20 - 9.94

TAS ≥ 160 mmHg

8 (38.1%)

11 (78.6%)

0.30

1.77

0.60 - 5.25

TAD ≥ 100 mmHg

9 (42.9%)

7 (50%)

0.24

2.14

0.59 - 7.77

Biological signs

Hb level < 8 g/dl

15 (71.4%)

7 (50%)

0.05

2.86

0.96 - 8.46

Hypocalcemia

14 (66.7%)

13 (92.8%)

0.92

0.99

0.39 - 2.53

Hyperphosphatemia

11 (52.4%)

7 (50%)

0.39

1.68

0.51 - 5.56

CRP ≥ 20 mg/l

19 (90.5%)

12 (85.7%)

0.03

2.71

1.1 - 6.68